Evidence map›Paper›PMID 28270768›Full record

ArticleFrontiers in pharmacology2017

Extracts of Immature Orange

Naoto Okada, Aki Murakami, Shiori Urushizaki, Misa Matsuda, Kazuyoshi Kawazoe, Keisuke Ishizawa

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Flavonoids fromChinese medicine · 2020
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Potential Metabolic Drug-Drug Interaction ofFrontiers in pharmacology · 2018
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Naoto OkadaDepartment of Clinical Pharmacy Practice Pedagogy, Institute of Biomedical Sciences, Tokushima University Graduate SchoolTokushima, Japan; Department of Pharmacy, Tokushima University HospitalTokushima, Japan.
Aki MurakamiDepartment of Pharmacy, Tokushima University Hospital Tokushima, Japan.
Shiori UrushizakiFaculty of Pharmaceutical Sciences, Tokushima University Tokushima, Japan.
Misa MatsudaFaculty of Pharmaceutical Sciences, Tokushima University Tokushima, Japan.
Kazuyoshi KawazoeDepartment of Clinical Pharmacy Practice Pedagogy, Institute of Biomedical Sciences, Tokushima University Graduate School Tokushima, Japan.
Keisuke IshizawaDepartment of Pharmacy, Tokushima University HospitalTokushima, Japan; Department of Clinical Pharmacy, Institute of Biomedical Sciences, Tokushima University Graduate SchoolTokushima, Japan.
Tokushima University · JPTokushima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P-glycoprotein (P-gp) and cytochrome P450 3A4 (CYP3A4) are expressed in the intestine and are associated with drug absorption and metabolism. Pregnane X receptor (PXR) is the key molecule that regulates the expression of P-gp and CYP3A4. Given that PXR activity is regulated by a variety of compounds, it is possible that unknown PXR activators exist among known medicines. Kampo is a Japanese traditional medicine composed of various natural compounds. In particular, immature orange [

Indexed as

citrus unshiu peelcytochrome P450 3A4Drug–Drug Interactionimmature orangeKampoP-glycoproteinpregnane X receptor

Identifiers

PMID28270768
PMCPMC5318391
OpenAlexW2591282736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.